Wall Street

Online Stock Market Trading By Armando Duke

thirds (61%) of the cancer specialists polled believe the FDA is too slow in approving new medical drugs and devices. image When doctors were asked if FDA regulations helped or prevented them from using promising new drugs or medical devices in the treatment of their patients, there was an almost even split. (43% Help, 44% Prevent) image Almost eight out of 10 (77%) responded that the FDA approval process has hurt their ability to treat their patients with the best possible care at least once in their medical careers.

Stock Investing Course (AXcess News) Washington - The Food and Drug Adminstration has tentatively approved Zidovudine for treatment of HIV/AIDS virus, a generic version of a child-friendly oral solution to help keep the AIDS virus from reproducing. Its available, except for Americans.

The experts were unanimous in advising that Genasense® should be approved, but the FDA was unmoved. The agency’s Dr. Pazdur suggested that Genta could make the drug available as an unapproved treatment through an expanded access program—this from a regulator fond of stating that the best way to get a drug to patients in need is through approval! We are not going to approve your drug, but any patient who needs it can have it, so long as you give it away.

Stock Market Game Zidovudine, manufactured by Aurobindo Pharma LTD. Hyderabad, India, is the first tentatively approved generic version of Retrovir brand of the zidovudine oral solution (manufactured by GlaxoSmithKline). This dosage form of the drug is the first child-friendly oral solution available for consideration for purchase under the President's Emergency Plan for AIDS Relief (PEPFAR).

FDA warning The Food and Drug Administration (FDA) has put out a bolded warning for severe liver injury after taking Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children. The labeling warns that severe liver injury may progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients. marketing adverse events.

Stock Investing Game "Working together with colleagues in the Department of Health and Human Services and the Office of the US Global AIDS Coordinator, FDA is delighted to help to ensure that the HIV/AIDS products available to children through the President's Emergency Program are safe and effective," said Dr. Murray M. Lumpkin, Deputy Commissioner for International and Special Programs.

WEDNESDAY, July 12 (HealthDay News) - AIDS gained approval Wednesday from the U.S. Food and Drug Administration and will soon be available to patients.

Journal Prime Rate Street Wall The Emergency Plan for AIDS Relief, which President Bush first announced in his 2003 State of the Union Address, is currently providing $15 billion to fight the HIV/AIDS pandemic over five years, with a special focus on 15 of the hardest-hit countries. The President's Emergency Plan is designed to prevent seven million new HIV infections, treat at least two million HIV-infected people, and care for ten million HIV-affected individuals, AIDS orphans and vulnerable children.

inflammatory corticosteroid drug. SARs patients who were given these drugs in the disease's early stages showed the best response. viral drug therapy early in a viral disease process has proven efficacy. For example, if a person was exposed to the influenza virus, the FDA approved drug Tamiflu® can prevent most infections if taken before symptoms manifest. If Tamiflu is taken as soon as flu symptoms develop, the average duration of illness can be reduced.

Stock Market News While it's great news for the world's poor and under-insured,that aid does nothingfor the growing number of Americans who cannot afford health insurance or the sky-rocketing costs of medications.

Stock Investing Basics Treatment for HIV in the United States costs on average, $1,000 a month for medication and without medical insurance few have the help needed to combat that disease. Many sufferers of HIV are left with little hope in surviving the disease that leads to AIDS in the first place. If President Bush wants to help, his administration - along with the mega-pharmaceutical giants like GlaxoSmithKline - should pay attention to Americans medical needs in addition to the poor in other parts of the world.

Stock Investing Software TheFDA's tentative approval means that although existing patents and/or exclusivity prevent marketing of this product in the United States , even though it meets all of HHS and FDA's quality, safety and efficacy standards for U.S. marketing. What that means is Americans cannot get cheaper generic drugs - they must pay through the nose instead and the ending result is billions in profits for the US drug manufacturers at the expense of thousands of Americans lives. And that's what Bush calls his "emergency plan for AIDS relief".

[ Comment, Edit or Article Submission ]